Market Overview

The global veterinary medicine market was valued at USD 37.4 Billion in 2024 and is expected to grow to USD 60.4 Billion by 2033. It is projected to expand at a CAGR of 5.47% during the forecast period of 2025-2033. Growth is driven by factors such as increasing pet ownership, technological progress in diagnostics and treatment, rising demand for food safety, and government initiatives promoting animal health. 

Study Assumption Years

  • Base Year: 2024
  • Historical Years: 2019-2024
  • Forecast Period: 2025-2033

Veterinary Medicine Market Key Takeaways

  • Current Market Size: USD 37.4 Billion (2024)
  • CAGR: 5.47% (2025-2033)
  • Forecast Period: 2025-2033
  • The global veterinary medicine market is propelled by the rising trend of pet ownership, especially in urban areas.
  • Production animals dominate the market, accounting for the largest share due to the demand for meat, milk, and animal-derived products.
  • Parenteral route of administration constitutes the largest segment, favored for its rapid absorption and precise dosing.
  • Veterinary hospitals and clinics are the biggest distribution channel, offering extensive services and access to a variety of veterinary products.
  • North America is the largest regional market owing to established veterinary healthcare infrastructure and significant investment in veterinary R&D.

Sample Request Link: https://www.imarcgroup.com/veterinary-medicine-market/requestsample

Market Growth Factors

The increasing pet ownership trend is a major growth driver for the veterinary medicine market. Pet owners are more aware and willing to invest in preventive care such as vaccinations and regular checkups, which has increased demand for veterinary services. Emotional bonds between pets and owners further fuel spending on animal healthcare, encouraging clinics and pharmaceutical companies to grow their offerings.

Technological advancements have significantly influenced market growth. Innovations such as digital radiography, ultrasound, advanced laboratory testing, and minimally invasive surgical techniques have improved the quality and effectiveness of veterinary care. These technologies provide quicker and more precise diagnoses and treatments, increasing the demand for veterinary services equipped with state-of-the-art equipment.

The livestock production and food safety sector drives demand due to the growing global population and rising meat consumption. Veterinary medicine ensures animal health, welfare, and food safety by enabling disease prevention, herd management, and improved productivity. Investments in veterinary medicine help maintain food safety standards and meet consumer demand for animal-derived products under ethical and efficient production methods.

Market Segmentation

By Product:

  • Drugs: Include anti-infective, anti-inflammatory, and parasiticide pharmaceuticals used for the treatment and management of animal diseases.
  • Vaccines: Include inactivated, attenuated, and recombinant vaccines that stimulate immune response to prevent infectious diseases.
  • Medicated Feed Additives: Comprise amino acids and antibiotics added to animal feed to deliver medication or nutritional supplements enhancing animal health and growth.

By Animal Type:

  • Production: Covers livestock and poultry including cattle, swine, poultry, sheep, and fish, mainly for meat, milk, and eggs, focusing on disease prevention and herd health.
  • Companion: Includes domestic pets like dogs, cats, and exotic pets, with veterinary care encompassing vaccinations, routine check-ups, dental care, and treatment.

By Route of Administration:

  • Oral: Delivery of medications through tablets, capsules, liquids, or feed additives, preferred for ease and controllable dosing.
  • Parenteral: Administration through injections or infusions, preferred for rapid absorption and precise dosing, representing the largest market share.
  • Topical: Application of medication to skin or mucous membranes, used for localized treatment like skin conditions and parasite control.

By Distribution Channel:

  • Veterinary Hospitals and Clinics: The largest channel, these facilities provide exams, diagnostics, treatments, and access to veterinary medications.
  • Point-of-Care Testing/In-house Testing: On-site diagnostic testing at clinics for immediate results facilitating timely treatment decisions.
  • Others: Include additional channels not specifically detailed.

Regional Insights

North America holds the largest market share in the global veterinary medicine market. Factors contributing to this dominance include a well-established veterinary healthcare system, increasing pet ownership, rising demand for quality animal healthcare, and robust investment in veterinary research and development. The region's stringent animal health regulations and developed infrastructure further boost market growth.

Recent Developments & News

In April 2022, Elanco Animal Health Incorporated collaborated with Ginkgo Bioworks to launch BiomEdit, a microbiome innovation company that will develop novel probiotics and microbial medicines for animal health. Ceva Santé Animale acquired Artemis Technologies Inc., enhancing its rabies combat product portfolio. Archer-Daniels-Midland Company obtained a license for Gnubiotics AMOBIOME, a prebiotic targeting beneficial gut bacteria in animal feed and supplements.

Key Players

  • Archer-Daniels-Midland Company
  • Boehringer Ingelheim GmbH
  • Cargill Incorporated
  • Ceva Santé Animale
  • Dechra Pharmaceuticals PLC
  • Elanco Animal Health Incorporated
  • Evonik Industries AG
  • Merck & Co. Inc.
  • Neogen Corporation
  • Vetoquinol S.A.
  • Virbac
  • Zoetis Inc.

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

Request For Customization: https://www.imarcgroup.com/request?type=report&id=5627&flag=E

About Us

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provides a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: sales@imarcgroup.com

Tel No: (D) +91 120 433 0800

United States: +1-201971-6302